Skip to main content
Fig. 5 | BMC Gastroenterology

Fig. 5

From: RFC2 promotes aerobic glycolysis and progression of colorectal cancer

Fig. 5

RFC2 activates the MET/PI3K/AKT/mTOR pathway in CRC cells. A Results from GSEA forecast. B Correlation analysis between RFC2 and MET based on TCGA-COAD datasets using Pearson’s correlation analysis. C MET protein expression in cells was measured using western blot. D Representative protein expression in the PI3K/AKT/mTOR pathway was measured using western blot. *p < 0.05 vs. si-NC or Vector group

Back to article page